Results 61 to 70 of about 27,643 (258)

Acute kidney injury in critically ill cancer patients : an update [PDF]

, 2016
Patients with cancer represent a growing group among actual ICU admissions (up to 20 %). Due to their increased susceptibility to infectious and noninfectious complications related to the underlying cancer itself or its treatment, these patients ...
Benoit, Dominique, Lameire, Norbert, Van Biesen, Wim, Vanholder, Raymond   +3 more
core   +2 more sources

Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial. [PDF]

, 2018
Background:For phosphate control, patient education is essential due to the limited clearance of phosphate by dialysis. However, well-designed randomized controlled trials about dietary and phosphate binder education have been scarce. Methods:We enrolled
Hyun, Sunah, Jeong, Jong Cheol, Kim, Heungsoo, Kim, Seirhan, Lee, Jae Myeong, Lee, Min-Jeong, Lee, Sun-Mi, Lim, Eunsoo, Morisky, Donald E, Oh, Ye-Sung, Park, Inwhee, Shin, Gyu-Tae   +11 more
core   +2 more sources

An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations

Expert opinion on therapeutic targets, 2020
Introduction: The management of hyperphosphatemia in patients with chronic kidney disease (CKD) is complicated, requiring a multidisciplinary approach that includes dietary phosphate restriction, dialysis, and phosphate binders.
M. Cozzolino, M. Ketteler, C. Wagner
semanticscholar   +1 more source

Hyperphosphatemia-Induced Oxidant/Antioxidant Imbalance Impairs Vascular Relaxation and Induces Inflammation and Fibrosis in Old Mice

Antioxidants, 2021
Aging impairs vascular function, but the mechanisms involved are unknown. The aim of this study was to analyze whether aging-related hyperphosphatemia is implied in this effect by elucidating the role of oxidative stress.
Ana Asenjo-Bueno, Elena Alcalde-Estévez, Mariam El Assar, Gemma Olmos, Patricia Plaza, Patricia Sosa, Patricia Martínez-Miguel, María Piedad Ruiz-Torres, Susana López-Ongil   +8 more
doaj   +1 more source

The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing-receptor (CaSR) mutation:relevance to autosomal dominant hypocalcemia type 1 (ADH1) [PDF]

, 2015
Autosomal dominant hypocalcemia type 1 (ADH1) is caused by germline gain-of-function mutations of the calcium-sensing receptor (CaSR) and may lead to symptomatic hypocalcemia, inappropriately low serum parathyroid hormone (PTH) concentrations and ...
Allen M. Spiegel, Breitwieser, Dong, Drude, Enikö Kallay, Fadil M. Hannan, Gerard V. Walls, Gowen, Hannan, Hannan, Harding, Hofer, Hough, Hu, Hu, Huang, Jianxin Hu, John, Kinoshita, Kumar, Leach, Leach, Letz, Letz, Lia-Baldini, Loupy, M. Andrew Nesbit, Miedlich, Nemeth, Nemeth, Nesbit, Pearce, Pearce, Petrel, Rajesh V. Thakker, Raue, Roger D. Cox, Stechman, Tertius A. Hough, Thim, Valerie N. Babinsky, Vargas-Poussou, Watanabe, William D. Fraser, Yamamoto   +44 more
core   +1 more source

Clinical Characteristics and Outcomes of Hyperphosphatemia in Patients with Chronic Kidney Disease Stages 1–2

Kidney & Blood Pressure Research
Introduction: There was limited research on the epidemiology of hyperphosphatemia in early-stage chronic kidney disease (CKD) patients. We aimed to explore the clinical characteristics and prognostic value of hyperphosphatemia in patients with CKD stages
Chao Xie, Qi Gao, Jiao Liu, Licong Su, Mingzhen Pang, Shiyu Zhou, Yaozhong Kong, Sheng Nie, Min Liang   +8 more
doaj   +1 more source

Recombinant human parathyroid hormone in the therapy of hypoparathyroidism [PDF]

Терапевтический архив, 2017
Hypoparathyroidism is an endocrine disease that results from deficiency or complete absence of parathyroid hormone (PTH), a biologically active 84-amino acid polypeptide.
A K Eremkina, N G Mokrysheva, E V Kovaleva, Yu A Krupinova   +3 more
doaj   +1 more source

The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease. [PDF]

, 2013
For a number of years, there has been increasing interest in the concept of directly targeting intestinal phosphate transport to control hyperphosphatemia in chronic kidney disease. However, progress has been slow due to the paucity of information on the
Debnam, ES, Marks, J, Unwin, RJ
core   +1 more source

The Effect of Magnesium Oxide on Hyperphosphatemia in Female Hemodialysis Patients [PDF]

Women’s Health Bulletin, 2014
Background: Hyperphosphatemia is a common problem in hemodialysis patients for which various binders are used to control this problem. Objectives: This study aims to assess the effect of magnesium oxide on controlling serum phosphorus levels and evaluate
Maryam Pakfetrat, Shokouh Sharifpour, Leila Malekmakan, Shahrokh Ezzatzadegan Jahromi, Jamshid Roozbeh, Amir Aslani   +5 more
doaj   +1 more source

State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective.

American Journal of Kidney Diseases, 2020
Phosphate binders are among the most common medications prescribed to patients with kidney failure on dialysis and are often used in advanced chronic kidney disease (CKD).
J. Scialla, J. Kendrick, J. Uribarri, C. Kovesdy, O. Gutiérrez, E. Jimenez, H. Kramer   +6 more
semanticscholar   +1 more source